skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover assunto: Treatment Outcome remover ScienceDirect Additional Titles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study

Levy, Mitchell M, Prof ; Artigas, Antonio, Prof ; Phillips, Gary S, MAS ; Rhodes, Andrew, MBBS ; Beale, Richard, MBBS ; Osborn, Tiffany, MD ; Vincent, Jean-Louis, Prof ; Townsend, Sean, MD ; Lemeshow, Stanley, Prof ; Dellinger, R Phillip, Prof

The Lancet infectious diseases, 2012-12, Vol.12 (12), p.919-924 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Eron, Joseph J, Prof ; Rockstroh, Jürgen K, MD ; Reynes, Jacques, Prof ; Andrade-Villanueva, Jaime, MD ; Ramalho-Madruga, Jose Valdez, MD ; Bekker, Linda-Gail, MD ; Young, Benjamin, MD ; Katlama, Christine, MD ; Gatell-Artigas, Jose Maria, MD ; Arribas, Jose R, MD ; Nelson, Mark, MD ; Campbell, Havilland, BS ; Zhao, Jing, PhD ; Rodgers, Anthony J, MS ; Rizk, Matthew L, PhD ; Wenning, Larissa, PhD ; Miller, Michael D, PhD ; Hazuda, Daria, PhD ; DiNubile, Mark J, MD ; Leavitt, Randi, MD ; Isaacs, Robin, MD ; Robertson, Michael N, MD ; Sklar, Peter, MD ; Nguyen, Bach-Yen, Dr

The Lancet infectious diseases, 2011-12, Vol.11 (12), p.907-915 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Sax, Paul E, Dr Prof ; Wohl, David, MD ; Yin, Michael T, Prof ; Post, Frank, MD ; DeJesus, Edwin, MD ; Saag, Michael, MD ; Pozniak, Anton, MD ; Thompson, Melanie, MD ; Podzamczer, Daniel, MD ; Molina, Jean Michel, Prof ; Oka, Shinichi, MD ; Koenig, Ellen, MD ; Trottier, Benoit, MD ; Andrade-Villanueva, Jaime, MD ; Crofoot, Gordon, MD ; Custodio, Joseph M, PharmD ; Plummer, Andrew, MS ; Zhong, Lijie, PhD ; Cao, Huyen, MD ; Martin, Hal, MD ; Callebaut, Christian, PhD ; Cheng, Andrew K, MD ; Fordyce, Marshall W, MD ; McCallister, Scott, MD

The Lancet (British edition), 2015-06, Vol.385 (9987), p.2606-2615 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Eron, Joseph J, Prof ; Cooper, David A, Prof ; Steigbigel, Roy T, Prof ; Clotet, Bonaventura, MD ; Gatell, Jose M, Prof ; Kumar, Princy N, Prof ; Rockstroh, Jurgen K, Prof ; Schechter, Mauro, Prof ; Markowitz, Martin, Prof ; Yeni, Patrick, MD ; Loutfy, Mona R, MD ; Lazzarin, Adriano, Prof ; Lennox, Jeffrey L, Prof ; Strohmaier, Kim M, BS ; Wan, Hong, MS ; Barnard, Richard JO, PhD ; Nguyen, Bach-Yen T, MD ; Teppler, Hedy, MD

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.